Fact CheckerSign in

NCT05083442Completed

Low-level Laser and Lifestyle Modifications

A Feasibility Study Addressing the Adjunct Use of Low-Level Laser to Mayo Lifestyle Modification Education and Wellness Coaching for Reducing Central Adiposity and Fat Mass

Source: ClinicalTrials.gov · Last updated 3 Apr 2025

Brief summary (registry, in English)

The purpose of this research study is to evaluate the effectiveness of Low Level Laser Therapy in combination with Lifestyle Modifications in helping people reduce the extra weight and size in the central body region

Status (registry)
Completed
Study type
Interventional
Enrollment
60 (actual)
First submitted
6 Oct 2021
Start date
1 Jun 2022
Primary completion date
30 Apr 2024
Lead sponsor
Mayo Clinic
Diseases
Obesity
NCT number
NCT05083442

What you commit to

  • Study type: Interventional
  • Participants enrolled: 60
  • From 1 Jun 2022 to the primary completion date, 30 Apr 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • have used weight loss medications or participated in a weight loss program within the past 30 days
  • are currently taking medications or supplements known to affect weight, such as insulin or sulfonylurea, prednisone or garcinia cambrogia
  • have used an investigational drug within 30 days of study enrollment
  • Reports being currently pregnant, lactating, or are of child-bearing potential or are likely to become pregnant during the low-level laser therapy treatment phase and are unwilling to use a reliable form of contraception. Acceptable forms include:
    • Hormonal methods, such as birth control pills, patches, injections, vaginal ring, or implants
    • Barrier methods (such as a condom or diaphragm) used with a spermicide (a foam, cream, or gel that kills sperm)
    • Intrauterine device (IUD)
    • Total hysterectomy or tubal ligation
    • Abstinence (no sex)
  • surgical intervention for body sculpting/weight loss, such as liposuction, abdominoplasty, stomach stapling, lap band surgery, etc. within 12 months prior to enrollment
  • active infection, wound or other external trauma to the areas to be treated with the laser
  • current active cancer or currently receiving treatment for cancer; or

Other illness

  • have a known active eating disorder
  • have a known, active, untreated clinically significant psychiatric condition (alcohol or substance abuse, psychosis, bipolar disorder, or depression)
  • have a history of any major cardiovascular events including heart valve disease, ongoing angina, cardiac arrhythmias, congestive heart failure, acute coronary syndrome, stroke, transient ischemic attack, or peripheral vascular disease
  • have current uncontrolled hypertension (systolic \> 160 mm Hg or diastolic \> 95 mm Hg) documented on 2 separate occasions
  • have clinically significant acute or chronic progressive or unstable neurologic, hepatic, renal, cardiovascular, lymphatic, respiratory, or metabolic disease (such as uncontrolled diabetes type 2) or active cancer or are within 1 year of cancer remission
  • any medical condition known to affect weight levels and/or to cause bloating or swelling
  • a diagnosis of, and/or taking medication for, irritable bowel syndrome
  • known photosensitivity disorder
  • have a known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder adherence

Other

  • have had weight fluctuations of 5 pounds or more in the past month
  • have an implanted device (including pacemaker or lap band) in the targeted area of LLLT
  • medical, physical, or other contraindications for body sculpting/weight loss

Who the study is looking for

  • 18 years of age or older
  • have a BMI 25-39.9 kg/m2
  • be able to participate fully in all aspects of the study; and
  • have understood and signed study informed consent

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Mayo Clinic
Coordinator of this site? Confirm its status
RochesterUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.